Clarify Medical has raised $1 million from 7 investors as part of a $1.5 million offering, according to a document filed with the SEC this week.
The San Diego, California-based company has not publicly clarified how it plans to spend its new funds. Clarify Medical sells an at-home light therapy device designed for people living with psoriasis and vitiligo.
The company’s system uses narrowband ultraviolet B rays to penetrate the skin and slow the growth of affected skin cells. Studies have found that narrowband UVB rays help to clear psoriasis faster compared to broadband UVB, according to Clarify Medical.
UVB light also triggers melanocytes, helping to repigment the skin in people with vitiligo, the company explains on its website.
The company’s at-home handheld system can also be synced with a user’s smartphone. Once the device is connected via iPhone or Android, the user can control and customize the dosage, frequency and duration of their treatment.
The company touts its system as more cost-effective than oral medications or office-based phototherapy used to treat auto-immune skin disorders. According to Clarify Medical’s website, the device is available for five monthly payments of $199.
